Trice Medical closed a US $19.3MM Series C financing. Funds will support U.S. marketing and ex-U.S. regulatory approvals for the mi-eye2™ system.
AMB Surgical received an investment to support prototype development of the Flyte Automated Growing Rod for the treatment of juvenile scoliosis, traumatic injuries, etc.
Arthromeda closed an undisclosed Series D financing to support the ArthroSight-PS Hip Alignment System through commercial regulatory approvals and clinical validation.Â
Independent analysis of 10,605 ATTUNE® Knee procedures showed a cumulative revision rate of 1.3% at 4 years vs. a 1.9% cumulative revision rate for the overall class of total knee replacement.